Gulf Coast Vision Center - Medicare Optometrist in Pensacola, FL

Gulf Coast Vision Center is a medicare enrolled "Optometrist" provider in Pensacola, Florida. Their current practice location is 460 E Nine Mile Rd, Pensacola, Florida. You can reach out to their office (for appointments etc.) via phone at (850) 477-1499.

Gulf Coast Vision Center is licensed to practice in Florida (license number OPC3828) and it also participates in the medicare program. Gulf Coast Vision Center is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1023164662.

Contact Information

Gulf Coast Vision Center
460 E Nine Mile Rd,
Pensacola, FL 32514-1441
(850) 477-1499
(850) 479-3359



Healthcare Provider's Profile

Full NameGulf Coast Vision Center
TypeFacility
SpecialityOptometrist
Location460 E Nine Mile Rd, Pensacola, Florida
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1023164662
  • Provider Enumeration Date: 01/26/2007
  • Last Update Date: 07/08/2011
  Medicare PECOS Information:
  • PECOS PAC ID: 3375584295
  • Enrollment ID: O20050520000084

Medical Identifiers

Medical identifiers for Gulf Coast Vision Center such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023164662NPI-NPPES
DD4676OtherFLMEDICARE RAILROAD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist OPC3828 (Florida)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Gulf Coast Vision Center acts as a billing entity for following providers:
Provider NameClyde D Reynolds
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1811975634
PECOS PAC ID: 2860382108
Enrollment ID: I20040318001416

News Archive

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

Patients, partners affected by colorectal cancer course

Partners of individuals with colorectal cancer, as well as the patients themselves, are at risk for psychologic morbidity according to the type of treatment given, show Portuguese study results.

The Economist examines factors contributing to antimicrobial resistance

"Antibiotic resistance has now become a costly and dangerous problem," The Economist writes in an article examining the factors that have contributed to the global rise of antibiotic resistant bacteria, ahead of next week's World Health Day dedicated to the issue.

Serametrix and the Ludwig Institute for Cancer Research form a partnership

Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.

Study quantifies health effects of Delhi's environmental interventions

Recent radical changes in air quality regulations in Delhi, India, have had a substantial positive effect on the health of city residents, according to new research co-authored by Andrew Foster, professor of economics and community health and an associate at Brown's Population Studies and Training Center.

Read more Medical News

› Verified 8 days ago

Provider NameBrandi C Slapkunas
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1619257789
PECOS PAC ID: 7810150646
Enrollment ID: I20120515000349

News Archive

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

Patients, partners affected by colorectal cancer course

Partners of individuals with colorectal cancer, as well as the patients themselves, are at risk for psychologic morbidity according to the type of treatment given, show Portuguese study results.

The Economist examines factors contributing to antimicrobial resistance

"Antibiotic resistance has now become a costly and dangerous problem," The Economist writes in an article examining the factors that have contributed to the global rise of antibiotic resistant bacteria, ahead of next week's World Health Day dedicated to the issue.

Serametrix and the Ludwig Institute for Cancer Research form a partnership

Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.

Study quantifies health effects of Delhi's environmental interventions

Recent radical changes in air quality regulations in Delhi, India, have had a substantial positive effect on the health of city residents, according to new research co-authored by Andrew Foster, professor of economics and community health and an associate at Brown's Population Studies and Training Center.

Read more Medical News

› Verified 8 days ago

Provider NameHannah M Sahawneh
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1992290191
PECOS PAC ID: 7810249158
Enrollment ID: I20190918002607

News Archive

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

Patients, partners affected by colorectal cancer course

Partners of individuals with colorectal cancer, as well as the patients themselves, are at risk for psychologic morbidity according to the type of treatment given, show Portuguese study results.

The Economist examines factors contributing to antimicrobial resistance

"Antibiotic resistance has now become a costly and dangerous problem," The Economist writes in an article examining the factors that have contributed to the global rise of antibiotic resistant bacteria, ahead of next week's World Health Day dedicated to the issue.

Serametrix and the Ludwig Institute for Cancer Research form a partnership

Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.

Study quantifies health effects of Delhi's environmental interventions

Recent radical changes in air quality regulations in Delhi, India, have had a substantial positive effect on the health of city residents, according to new research co-authored by Andrew Foster, professor of economics and community health and an associate at Brown's Population Studies and Training Center.

Read more Medical News

› Verified 8 days ago

Provider NameStephen Thomas Tipton
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1730698010
PECOS PAC ID: 2961818729
Enrollment ID: I20210303001193

News Archive

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

Patients, partners affected by colorectal cancer course

Partners of individuals with colorectal cancer, as well as the patients themselves, are at risk for psychologic morbidity according to the type of treatment given, show Portuguese study results.

The Economist examines factors contributing to antimicrobial resistance

"Antibiotic resistance has now become a costly and dangerous problem," The Economist writes in an article examining the factors that have contributed to the global rise of antibiotic resistant bacteria, ahead of next week's World Health Day dedicated to the issue.

Serametrix and the Ludwig Institute for Cancer Research form a partnership

Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.

Study quantifies health effects of Delhi's environmental interventions

Recent radical changes in air quality regulations in Delhi, India, have had a substantial positive effect on the health of city residents, according to new research co-authored by Andrew Foster, professor of economics and community health and an associate at Brown's Population Studies and Training Center.

Read more Medical News

› Verified 8 days ago

Provider NameTyler James Ridder
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1275269813
PECOS PAC ID: 5991188740
Enrollment ID: I20220811003197

News Archive

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

Patients, partners affected by colorectal cancer course

Partners of individuals with colorectal cancer, as well as the patients themselves, are at risk for psychologic morbidity according to the type of treatment given, show Portuguese study results.

The Economist examines factors contributing to antimicrobial resistance

"Antibiotic resistance has now become a costly and dangerous problem," The Economist writes in an article examining the factors that have contributed to the global rise of antibiotic resistant bacteria, ahead of next week's World Health Day dedicated to the issue.

Serametrix and the Ludwig Institute for Cancer Research form a partnership

Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.

Study quantifies health effects of Delhi's environmental interventions

Recent radical changes in air quality regulations in Delhi, India, have had a substantial positive effect on the health of city residents, according to new research co-authored by Andrew Foster, professor of economics and community health and an associate at Brown's Population Studies and Training Center.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gulf Coast Vision Center is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Gulf Coast Vision Center
460 E Nine Mile Rd,
Pensacola, FL 32514-1441

Ph: (850) 477-1499
Gulf Coast Vision Center
460 E Nine Mile Rd,
Pensacola, FL 32514-1441

Ph: (850) 477-1499

News Archive

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

Patients, partners affected by colorectal cancer course

Partners of individuals with colorectal cancer, as well as the patients themselves, are at risk for psychologic morbidity according to the type of treatment given, show Portuguese study results.

The Economist examines factors contributing to antimicrobial resistance

"Antibiotic resistance has now become a costly and dangerous problem," The Economist writes in an article examining the factors that have contributed to the global rise of antibiotic resistant bacteria, ahead of next week's World Health Day dedicated to the issue.

Serametrix and the Ludwig Institute for Cancer Research form a partnership

Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.

Study quantifies health effects of Delhi's environmental interventions

Recent radical changes in air quality regulations in Delhi, India, have had a substantial positive effect on the health of city residents, according to new research co-authored by Andrew Foster, professor of economics and community health and an associate at Brown's Population Studies and Training Center.

Read more News

› Verified 8 days ago


Optometrist in Pensacola, FL

Jennifer M Werrell, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 8333 N. Davis Highway, West Flordia Medical Center Clinic Pa, Pensacola, FL 32514
Phone: 850-474-8220    Fax: 850-969-2187
Dr. Floyd Donald Colley, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 2105 Town St, Pensacola, FL 32505
Phone: 850-433-0327    Fax: 850-432-2159
Dr. Matthew Steven Owens, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 460 E Nine Mile Rd, Pensacola, FL 32514
Phone: 850-477-1499    
Dr Francis X. Albert, Od, Pa
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 7171 N Davis Hwy, Sears Optical, Pensacola, FL 32504
Phone: 850-479-7517    
James William Andrews, Od
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 5062 Mobile Hwy, Pensacola, FL 32506
Phone: 850-453-4373    Fax: 850-453-1953
Dr. Joseph Collin Tegenkamp, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 6700 N Davis Hwy, Pensacola, FL 32504
Phone: 850-434-6387    Fax: 850-432-0540

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.